Fluorescence in situ hybridization (FISH) on uncultured amniocytes and standard cytogenetic analysis after amniocentesis have been performed for 904 samples. The experience with the FISH method and its clinical relevance is described in a large clinical pilot study. Commercially available chromosome
Defining the efficiency of fluorescence in situ hybridization on uncultured amniocytes on a retrospective cohort of 27407 prenatal diagnoses
✍ Scribed by Patricia Lewin; Pascale Kleinfinger; Anne Bazin; Hossein Mossafa; Sylvie Szpiro-Tapia
- Publisher
- John Wiley and Sons
- Year
- 2000
- Tongue
- English
- Weight
- 77 KB
- Volume
- 20
- Category
- Article
- ISSN
- 0197-3851
No coin nor oath required. For personal study only.
✦ Synopsis
Rapid prenatal detection of selected numerical chromosomal abnormalities by using ¯uorescence in situ hybridization (FISH) on uncultured amniotic ¯uid samples was described six years ago. It allows a very rapid identi®cation of selected aneuploidies. We have indexed the results of our 27 407 fetal karyotypes obtained by conventional cytogenetics during the last ®ve years, noting the type of chromosomal abnormality and the reasons for prenatal diagnosis. We have also indexed the chromosomal abnormality regarding the prognosis of the chromosomal aberations to evaluate the real impact of a non-diagnosis. Within the population of bad prognosis abnormalities, the percentage of abnormalities with bad prognosis detectable by FISH is 94.6% for advanced maternal age, 85.3% for ultrasonographic anomalies and 86.4% for positive maternal screening. The use of FISH alone on our cohort is not a suitable method to diagnose the chromosomal abnormalities.
📜 SIMILAR VOLUMES
A probe was generated from the YAC clone 831B9 that was suitable for the prenatal detection of trisomy 21using fluorescence in situ hybridization (FISH). This probe was initially tested on a series of 650 unselected amniotic fluid samples prior to the karyotype being available. 630 were correctly id